State Street’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$85.2M Buy
749,754
+22,629
+3% +$2.57M ﹤0.01% 1394
2025
Q1
$76.4M Sell
727,125
-16,507
-2% -$1.74M ﹤0.01% 1408
2024
Q4
$79.7M Buy
743,632
+36,218
+5% +$3.88M ﹤0.01% 1481
2024
Q3
$70.8M Buy
707,414
+18,642
+3% +$1.87M ﹤0.01% 1521
2024
Q2
$58M Buy
688,772
+17,488
+3% +$1.47M ﹤0.01% 1587
2024
Q1
$49.1M Buy
671,284
+3,000
+0.4% +$219K ﹤0.01% 1739
2023
Q4
$47.7M Buy
668,284
+45,029
+7% +$3.22M ﹤0.01% 1727
2023
Q3
$37.3M Buy
623,255
+10,643
+2% +$638K ﹤0.01% 1794
2023
Q2
$44.2M Sell
612,612
-32,946
-5% -$2.38M ﹤0.01% 1748
2023
Q1
$47.5M Sell
645,558
-4,356
-0.7% -$320K ﹤0.01% 1682
2022
Q4
$43.4M Sell
649,914
-875,049
-57% -$58.5M ﹤0.01% 1734
2022
Q3
$81.9M Sell
1,524,963
-212,556
-12% -$11.4M 0.01% 1247
2022
Q2
$96.7M Sell
1,737,519
-12,625
-0.7% -$703K 0.01% 1169
2022
Q1
$123M Buy
1,750,144
+327,717
+23% +$23M 0.01% 1150
2021
Q4
$137M Sell
1,422,427
-49,468
-3% -$4.77M 0.01% 1060
2021
Q3
$128M Buy
1,471,895
+94,200
+7% +$8.19M 0.01% 1078
2021
Q2
$113M Buy
1,377,695
+122,931
+10% +$10.1M 0.01% 1206
2021
Q1
$119M Sell
1,254,764
-613,356
-33% -$58.3M 0.01% 1103
2020
Q4
$116M Buy
1,868,120
+310,602
+20% +$19.3M 0.01% 1040
2020
Q3
$92.6M Sell
1,557,518
-61,813
-4% -$3.68M 0.01% 1015
2020
Q2
$113M Sell
1,619,331
-388,840
-19% -$27.1M 0.01% 877
2020
Q1
$91.1M Sell
2,008,171
-1,529
-0.1% -$69.4K 0.01% 904
2019
Q4
$131M Sell
2,009,700
-27,216
-1% -$1.77M 0.01% 881
2019
Q3
$126M Buy
2,036,916
+150,244
+8% +$9.33M 0.01% 868
2019
Q2
$134M Sell
1,886,672
-182,012
-9% -$13M 0.01% 863
2019
Q1
$162M Buy
2,068,684
+457,775
+28% +$35.9M 0.01% 746
2018
Q4
$136M Buy
1,610,909
+232,151
+17% +$19.7M 0.01% 754
2018
Q3
$236M Sell
1,378,758
-81,137
-6% -$13.9M 0.02% 648
2018
Q2
$189M Sell
1,459,895
-63,418
-4% -$8.2M 0.02% 713
2018
Q1
$157M Sell
1,523,313
-27,633
-2% -$2.85M 0.01% 780
2017
Q4
$132M Buy
1,550,946
+184,522
+14% +$15.8M 0.01% 861
2017
Q3
$116M Buy
1,366,424
+65,378
+5% +$5.55M 0.01% 902
2017
Q2
$98.5M Sell
1,301,046
-61,943
-5% -$4.69M 0.01% 972
2017
Q1
$90M Buy
1,362,989
+2,053
+0.2% +$136K 0.01% 1012
2016
Q4
$86.3M Sell
1,360,936
-36,208
-3% -$2.3M 0.01% 981
2016
Q3
$88.9M Buy
1,397,144
+215,728
+18% +$13.7M 0.01% 940
2016
Q2
$87.9M Buy
1,181,416
+59,656
+5% +$4.44M 0.01% 896
2016
Q1
$74.9M Buy
1,121,760
+103,249
+10% +$6.9M 0.01% 965
2015
Q4
$68.9M Buy
1,018,511
+71,779
+8% +$4.85M 0.01% 997
2015
Q3
$50.6M Sell
946,732
-22,645
-2% -$1.21M 0.01% 1167
2015
Q2
$61M Sell
969,377
-68,303
-7% -$4.3M 0.01% 1146
2015
Q1
$49.9M Sell
1,037,680
-34,831
-3% -$1.68M 0.01% 1242
2014
Q4
$35.6M Buy
1,072,511
+34,871
+3% +$1.16M ﹤0.01% 1403
2014
Q3
$30.4M Buy
1,037,640
+120,750
+13% +$3.54M ﹤0.01% 1436
2014
Q2
$35.6M Sell
916,890
-28,032
-3% -$1.09M ﹤0.01% 1406
2014
Q1
$39.6M Sell
944,922
-63,301
-6% -$2.66M ﹤0.01% 1328
2013
Q4
$33.1M Sell
1,008,223
-213,265
-17% -$7M ﹤0.01% 1432
2013
Q3
$33M Buy
1,221,488
+403,762
+49% +$10.9M ﹤0.01% 1396
2013
Q2
$19.1M Buy
+817,726
New +$19.1M ﹤0.01% 1658